Henric Bjarke - Dec 15, 2022 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role: SVP, COO
Signature: /s/ Henric Bjarke
Stock symbol: INZY
Transactions as of: Dec 15, 2022
Transactions value $: $29,885
Form type: 4
Date filed: 12/19/2022, 07:30 AM
Previous filing: Oct 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INZY	Common Stock	Purchase	$29.9K	+21.5K	+25.61%	$1.39	105K	Dec 15, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.